Vanguard Group’s Cognition Therapeutics CGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $404K | Buy |
1,304,350
+65,183
| +5% | +$20.2K | ﹤0.01% | 3967 |
|
|
2025
Q1 | $522K | Sell |
1,239,167
-400
| -0% | -$168 | ﹤0.01% | 3877 |
|
|
2024
Q4 | $869K | Sell |
1,239,567
-2,987
| -0.2% | -$2.09K | ﹤0.01% | 3808 |
|
|
2024
Q3 | $583K | Buy |
1,242,554
+95,000
| +8% | +$44.6K | ﹤0.01% | 3932 |
|
|
2024
Q2 | $1.9M | Buy |
1,147,554
+225,874
| +25% | +$375K | ﹤0.01% | 3570 |
|
|
2024
Q1 | $1.68M | Buy |
921,680
+200,126
| +28% | +$364K | ﹤0.01% | 3647 |
|
|
2023
Q4 | $1.33M | Buy |
721,554
+34,658
| +5% | +$64.1K | ﹤0.01% | 3738 |
|
|
2023
Q3 | $989K | Buy |
686,896
+18,471
| +3% | +$26.6K | ﹤0.01% | 3832 |
|
|
2023
Q2 | $1.22M | Buy |
668,425
+25,035
| +4% | +$45.8K | ﹤0.01% | 3839 |
|
|
2023
Q1 | $1.27M | Buy |
643,390
+98,501
| +18% | +$195K | ﹤0.01% | 3843 |
|
|
2022
Q4 | $1.14M | Buy |
544,889
+143,686
| +36% | +$302K | ﹤0.01% | 3863 |
|
|
2022
Q3 | $762K | Buy |
401,203
+330,283
| +466% | +$627K | ﹤0.01% | 4083 |
|
|
2022
Q2 | $150K | Buy |
70,920
+12,324
| +21% | +$26.1K | ﹤0.01% | 4500 |
|
|
2022
Q1 | $161K | Buy |
58,596
+17
| +0% | +$47 | ﹤0.01% | 4560 |
|
|
2021
Q4 | $371K | Buy |
+58,579
| New | +$371K | ﹤0.01% | 4482 |
|